TheProfitWatch

CLNN - Clene Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.58 0.3 (3.5%) --- --- --- --- 0.3 (3.5%) --- ---

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.78
Diluted EPS:
Basic P/E:
-11.3846
Diluted P/E:
RSI(14) 1m:
72.41
VWAP:
8.85
RVol:
0.2404

Events

Period Kind Movement Occurred At
10m Price increase 10m 8.86 +0.28 (+3.26%) Oct 15 09:30

Related News